Dr. Wild & Co. (funding: investigator-initiated and independent grant) Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2015
NCT02419105
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

testosterone (delatestryl) (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypogonadism (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2